TGF-β levels significantly increases in patients with stage III and IV breast cancer and can be explored as a target for tumour diagnosis and staging.

IF 4.1 4区医学 Q2 IMMUNOLOGY

Scandinavian Journal of Immunology Pub Date : 2023-08-01 Epub Date: 2023-05-10 DOI:10.1111/sji.13280

Joshua M Mutiso, Ciriaka M Gitonga, Michael M Gicheru

引用次数: 0

查看原文本刊更多论文

TGF-β水平在III期和IV期乳腺癌患者中显著升高，可作为肿瘤诊断和分期的靶点。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Scandinavian Journal of Immunology 医学-免疫学

CiteScore

7.70

自引率

5.40%

发文量

109

审稿时长

1 months

期刊介绍： This peer-reviewed international journal publishes original articles and reviews on all aspects of basic, translational and clinical immunology. The journal aims to provide high quality service to authors, and high quality articles for readers. The journal accepts for publication material from investigators all over the world, which makes a significant contribution to basic, translational and clinical immunology.